T1	Participants 183 195	464 patients
T2	Participants 334 424	partially responding or sensitive relapsed patients with aggressive non-Hodgkin's lymphoma
T3	Participants 834 916	Patients were younger than 55 years and had at least one adverse prognostic factor
T4	Participants 1158 1170	464 patients
